Skip to main content

Table 3 Characteristics of patients with Facioscapulohumeral muscular dystrophy type 1 (FSHD1) at follow-up

From: Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study

  Presence of Late Gadolinium Enhancement
All (n = 40) No (n = 26) Yes (n = 14)
Age (years) 49 ± 14 47 ± 14 54 ± 11
Male sex, n (%) 29 (70.7) 9 (36) 3 (21.4)
Heart rate (beats per minute) 74 ± 13 76 ± 13 71 ± 14
Systolic BP (mmHg) 129 ± 15 127 ± 16 132 ± 15
Diastolic BP (mmHg) 79 ± 10 79 ± 9 79 ± 11
Arterial hypertension, n (%) 8 (20) 1 7
Hyperlipidemia, n (%) 7 (17.5) 3 4
Diabetes mellitus, n (%) 3 (7.5) 1 2
Smoking, n (%) 5 (12.5) 3 2
Cardiac symptoms
 Asymptomatic, n (%) 29 (70.7) 19 10
 Palpitations, n (%) 8 (12.2) 6 2
 Chest pain, n (%) 1(2.4) 1 0
 Fatigue, n (%) 6 (14.6) 4 2
  1. Data are shown as mean values ± standard deviation (SD) according to the AHA-segment model. BP blood pressure